Erdafitinib and Hyperphosphatemia
Result of checking the interaction of drug Erdafitinib and disease Hyperphosphatemia for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Increases in phosphate levels are a pharmacodynamic effect of erdafitinib. Hyperphosphatemia was reported as adverse reaction in 76% of patients after initiating treatment, with 32% requiring phosphate binders during treatment. Caution and monitoring of phosphate levels is advised in all patients, especially in those at risk or hyperphosphatemia. Follow the manufacturer's dose modification guidelines if required.
Erdafitinib - hiperfosfatemia 
Erdafitinib - hiperfosfatemia 
Erdafitinib - hiperfosfatemia 
Erdafitinib - hiperfosfatemia 
Erdafitinib - iperfosfatemia 
Erdafitinib - hyperphosphatémie 
Erdafitinib - Hyperphosphatämie 
Erdafitinib - hiperfosfatemia 
Erdafitinib - гиперфосфатемия 
Erdafitinib - hiperfosfatemi 
Erdafitinib - فرط فوسفات الدم 
Erdafitinib - 高磷酸盐血症